Autopsy report · NCT01555515

Epodure Therapy of Anemia in End Stage Renal Disease on Dialysis With Epodure Skin Implant

“New protocol to start with improved product”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 2 years 1 month before it stopped.
• 4 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 1, Phase 2

Sponsor

Medgenics Medical Israel Ltd.

Sponsor type

Industry

Conditions

Anemia; End Stage Renal Disease

Interventions

implantation of autologous skin graft after ex-vivo treatment; Subcutan implantation of autologus skin graft after ex-vivo treatment

Participants

4

Trials that died the same way

• Antithymocyte Globulin, Clofarabine, and Rituximab in Treating Patients After an Unsuccessful Stem Cell Transplant
  “Replaced by another protocol” (62% match in meaning)
• RCT for Women With a Persisting Pregnancy of Unknown Location
  “A new protocol was written to replace this protocol.” (61% match in meaning)
• Bacteriophage Therapy in Patients With Prosthetic Joint Infections
  “Changes to protocol design” (60% match in meaning)
• Nitric Oxide During Cardiopulmonary Bypass in Neonates to Reduce Risk of Acute Kidney Injury
  “revised and combined with another protocol” (59% match in meaning)
• Randomized Study to Evaluate Intranasal Dose of STI-2099 (COVI-DROPS™) in Outpatient Adults With Mild COVID-19 Infection
  “to be replaced with a different protocol” (58% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.